AIM
FBIO icon

Axiom Investment Management’s Fortress Biotech FBIO Stock Holding History

Axiom Investment Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52 Buy
+17
New +$44 ﹤0.01% 517
2022
Q4 		– Sell
-18
Closed – – 206
2022
Q3 		$0 Buy
+18
New +$270 ﹤0.01% 425
2021
Q2 		– Sell
-31
Closed -$2K – 174
2021
Q1 		$2K Buy
+31
New +$1.75K ﹤0.01% 192

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Axiom Investment Management's FBIO Position: Q2 2026 in Review

Axiom Investment Management opened a new position in Fortress Biotech (FBIO) in Q2 2026: 17 shares worth $52. The stake represents ﹤0.01% of the portfolio and ranks #517 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in FBIO as recently as Q3 2022.

Axiom Investment Management first reported a position in FBIO in Q1 2021 and has held it in 3 quarters since. The position peaked at $2K in Q1 2021. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Axiom Investment Management held 17 shares of Fortress Biotech worth $52 as of Q2 2026.
  • Fortress Biotech was a new Axiom Investment Management position in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Axiom Investment Management's portfolio in Q2 2026, its #517 holding.
  • Axiom Investment Management first reported a position in Fortress Biotech in Q1 2021 and has held it in 3 quarters since.
  • Axiom Investment Management's Fortress Biotech position peaked at $2K in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.